Cerovene, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 612 Corporate Way Suite 10, Valley Cottage, New York (NY) 10989, United States (USA)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 3005890568 · DUNS 790387927
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-03-23
- NAIDrug Quality Assurance2023-08-01
- NAIDrug Quality Assurance2018-11-05
- VAIDrug Quality Assurance2017-02-08
- VAIDrug Quality Assurance2015-05-04
- VAIDrug Quality Assurance2013-10-15
- NAIDrug Quality Assurance2012-09-20
- NAIDrug Quality Assurance2011-03-08
- NAIDrug Quality Assurance2010-01-04
Drugs this plant is listed as making
10 distinct drugs across 17 products name this site in their FDA label.
- Amphetamine Sulfate TabletsDr. Reddy's Laboratories Inc
- Diphenoxylate Hydrochloride and Atropine SulfateUnichem Pharmaceuticals (USA), Inc.
- FamotidineDr. Reddy's Laboratories Inc
- Fluphenazine HydrochlorideDr. Reddys Laboratories Inc.
- MetyrosineDr. Reddy's Laboratories Inc.
- midodrine hydrochlorideXiromed, LLC
- Primaquine PhosphateUnichem Pharmaceuticals (USA), Inc.
- pyrimethamineDr.reddys Laboratories Inc
- RamelteonXiromed, LLC
- ZolmitriptanJubilant Cadista Pharmacuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.